Cargando…

Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study

BACKGROUND: The development of metastasis is the primary cause of death in patients with non-small cell lung cancer (NSCLC). However, identifying those NSCLC patients who will have loco-regional or distant disease recurrence after surgery is still challenging. Circulating tumor cells (CTCs) can accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhao, Xu, Ke, Tartarone, Alfredo, Santarpia, Mariacarmela, Zhu, Yuming, Jiang, Gening
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947419/ https://www.ncbi.nlm.nih.gov/pubmed/33718038 http://dx.doi.org/10.21037/tlcr-21-149

Ejemplares similares

Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy
por: Tartarone, Alfredo, et al.
Publicado: (2022)

Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
por: Jiang, Jia-Hao, et al.
Publicado: (2022)

Octogenarians may benefit from stage-specific small cell lung cancer treatment
por: Zhou, Bin, et al.
Publicado: (2021)

Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
por: Bao, Yi, et al.
Publicado: (2021)

Comprehensive genomic profiling of combined small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2021)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need
por: Pretelli, Giulia, et al.
Publicado: (2023)

A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma
por: Chen, Ying, et al.
Publicado: (2022)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Wedge resection plus adequate lymph nodes resection is comparable to lobectomy for small-sized non-small cell lung cancer
por: Ding, Hongdou, et al.
Publicado: (2022)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
por: Santarpia, Mariacarmela, et al.
Publicado: (2021)

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2023)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report
por: Zeng, Zhen, et al.
Publicado: (2022)

Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer
por: Li, Zhaoxun, et al.
Publicado: (2023)

Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer
por: Dai, Jie, et al.
Publicado: (2022)

The importance both of early diagnosis and smoking cessation in the battle against lung cancer
por: Tartarone, Alfredo
Publicado: (2020)

Current Treatment Approaches for Thymic Epithelial Tumors
por: Tartarone, Alfredo, et al.
Publicado: (2023)

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass
por: Hashimoto, Masaki, et al.
Publicado: (2017)

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection
por: Bayarri-Lara, Clara, et al.
Publicado: (2016)

Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations
por: Guo, Kai, et al.
Publicado: (2021)

Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
por: Gao, Yina, et al.
Publicado: (2022)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
por: Lazzari, Chiara, et al.
Publicado: (2021)

Increased detection of circulating tumor DNA by short fragment enrichment
por: Liu, Yang, et al.
Publicado: (2021)

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
por: Torres, Jacqueline Aparecida, et al.
Publicado: (2023)

Two cases of carina resection for bronchogenic tumor with lung parenchyma sparing: A brief report
por: Aramini, Beatrice, et al.
Publicado: (2019)

Plasticity of circulating tumor cells in small cell lung cancer
por: Seo, Jiyoun, et al.
Publicado: (2023)

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development—a narrative review
por: Santarpia, Mariacarmela, et al.
Publicado: (2023)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
por: Rossi, Elisabetta, et al.
Publicado: (2021)

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
por: Santarpia, Mariacarmela, et al.
Publicado: (2020)

Focus on lung cancer screening
por: Tartarone, Alfredo, et al.
Publicado: (2020)

Prognosis of recurrent non-small cell lung cancer following complete resection
por: SASAKI, HIDEFUMI, et al.
Publicado: (2014)

Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database
por: Yang, Lan, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Treatment for non-small-cell lung cancer and circulating tumor cells
por: Mason, Joel, et al.
Publicado: (2017)

The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer
por: Yang, Yong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2chapkm0o32qqn3q9n5gmucn1v